Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P E Zorsky

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Seminars in Oncology|October 1, 1993
Optimizing high-dose therapy using pharmacokinetic principlesP E Zorsky, J B Perkins
Southern Medical Journal|March 1, 1993
Fine needle aspiration as a means to cost-effective health careY C Oertel, P E Zorsky
Journal of Molecular Biology|September 25, 1973
Letter: Preliminary crystallographic data for Escherichia coli beta-lactamaseJ R Knox, P E Zorsky, N S Murthy
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 1994
Ifosfamide, carboplatin, and etoposide: a new regimen with a broad spectrum of activityK K Fields, P E Zorsky, J W Hiemenz, et al.
Progress in Clinical and Biological Research|January 1, 1992
Salvage and transfusion of autologous red blood cells from bone marrow harvestW E Janssen, K Benson, C Lee, et al.
Progress in Clinical and Biological Research|January 1, 1992
Use of CD34+ cell fraction as a measure of hematopoietic stem cells in bone marrow and peripheral blood: comparison with the CFU-GM assayW E Janssen, C Lee, M J Farmelo, et al.
Surgical Oncology|January 1, 1993
Intensive dose ifosfamide, carboplatin, and etoposide followed by autologous stem cell rescue: results of a phase I/II study in breast cancer patientsK K Fields, J P Perkins, J W Hiemenz, et al.
Progress in Clinical and Biological Research|January 1, 1994
Mobilization of peripheral blood stem cells: comparing cyclophosphamide and growth factor based regimensW E Janssen, R Smilee, R Carter, et al.
Seminars in Oncology|October 1, 1993
Two novel high-dose treatment regimens for metastatic breast cancer--ifosfamide, carboplatin, plus etoposide and mitoxantrone plus thiotepa: outcomes and toxicitiesK K Fields, G J Elfenbein, J B Perkins, et al.
Seminars in Oncology|October 1, 1994
High-dose ifosfamide/carboplatin/etoposide: maximum tolerable doses, toxicities, and hematopoietic recovery after autologous stem cell reinfusionK K Fields, G J Elfenbein, J B Perkins, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Seminars in Oncology|October 1, 1993
Optimizing high-dose therapy using pharmacokinetic principlesP E Zorsky, J B Perkins
Southern Medical Journal|March 1, 1993
Fine needle aspiration as a means to cost-effective health careY C Oertel, P E Zorsky
Journal of Molecular Biology|September 25, 1973
Letter: Preliminary crystallographic data for Escherichia coli beta-lactamaseJ R Knox, P E Zorsky, N S Murthy
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 1994
Ifosfamide, carboplatin, and etoposide: a new regimen with a broad spectrum of activityK K Fields, P E Zorsky, J W Hiemenz, et al.
Progress in Clinical and Biological Research|January 1, 1992
Salvage and transfusion of autologous red blood cells from bone marrow harvestW E Janssen, K Benson, C Lee, et al.
Progress in Clinical and Biological Research|January 1, 1992
Use of CD34+ cell fraction as a measure of hematopoietic stem cells in bone marrow and peripheral blood: comparison with the CFU-GM assayW E Janssen, C Lee, M J Farmelo, et al.
Surgical Oncology|January 1, 1993
Intensive dose ifosfamide, carboplatin, and etoposide followed by autologous stem cell rescue: results of a phase I/II study in breast cancer patientsK K Fields, J P Perkins, J W Hiemenz, et al.
Progress in Clinical and Biological Research|January 1, 1994
Mobilization of peripheral blood stem cells: comparing cyclophosphamide and growth factor based regimensW E Janssen, R Smilee, R Carter, et al.
Seminars in Oncology|October 1, 1993
Two novel high-dose treatment regimens for metastatic breast cancer--ifosfamide, carboplatin, plus etoposide and mitoxantrone plus thiotepa: outcomes and toxicitiesK K Fields, G J Elfenbein, J B Perkins, et al.
Seminars in Oncology|October 1, 1994
High-dose ifosfamide/carboplatin/etoposide: maximum tolerable doses, toxicities, and hematopoietic recovery after autologous stem cell reinfusionK K Fields, G J Elfenbein, J B Perkins, et al.
Pageof 2